Cargando…
Drug repurposing in COVID-19: A review with past, present and future
The coronavirus SARS-CoV-2 which causes the COVID-19 disease is a global public health emergency. Coronavirus are single-stranded positive-sense RNA viruses and their genome size is approximately 30 kb, which encodes some important structural proteins. The interaction between viral Spike protein and...
Autores principales: | Srivastava, Kamna, Singh, Mohan Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387125/ https://www.ncbi.nlm.nih.gov/pubmed/34462734 http://dx.doi.org/10.1016/j.metop.2021.100121 |
Ejemplares similares
-
A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
por: Hossen, Md. Shafiul, et al.
Publicado: (2020) -
Neurological manifestations of coronavirus disease 2019: exploring past to understand present
por: Desai, Ishita, et al.
Publicado: (2021) -
Could COVID-19 Trigger a Rebirth in Anatomy Education? A Glimpse of Anatomists’ Responses to Pandemics of the Past and Present
por: Naidoo, N., et al.
Publicado: (2021) -
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021) -
Current and Future Challenges in the Delivery of Mental Healthcare during COVID-19
por: Gautam, Mohan, et al.
Publicado: (2020)